[Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].

Gakis, G; Volkmer, B; Qvick, B; Marteau, F; Stenzl, A

[Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder]. / Kosten-Effektivitäts-Analyse zur Verwendung der Blaulichtzystoskopie mit Hexylaminolevulinat bei der transurethralen Resektion der Harnblase.

Gakis, G; Volkmer, B; Qvick, B; Marteau, F; Stenzl, A.

Afiliação

Gakis G; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland.
Volkmer B; Klinik für Urologie, Klinikum Kassel, Kassel, Deutschland.
Qvick B; Ipsen Pharma GmbH, Ettlingen, Deutschland.
Marteau F; Ipsen Pharma, Boulogne-Billancourt, Frankreich.
Stenzl A; Klinik für Urologie, Universitätsklinikum Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Deutschland. Arnulf.Stenzl@med.uni-tuebingen.de.

Urologe A ; 58(1): 34-40, 2019 Jan.

Article em De | MEDLINE | ID: mdl-29637215

Assuntos

Cistoscopia; Neoplasias da Bexiga Urinária; Análise Custo-Benefício; Alemanha; Humanos; Recidiva Local de Neoplasia

Palavras-chave

Bladder cancer; Cost-effectiveness; Hexaminolevulinate; Markov model; Photodynamic diagnosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cistoscopia Tipo de estudo: Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Europa Idioma: De Revista: Urologe A Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google